HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not?
Reaven, Gerald M
HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not? [electronic resource] - Diabetes & vascular disease research Apr 2009 - 133-8 p. digital
Publication Type: Journal Article; Review
1752-8984
10.1177/1479164109336038 doi
Biomarkers--blood
Blood Glucose--metabolism
Clinical Trials as Topic
Diabetes Mellitus, Type 2--blood
Disease Progression
Evidence-Based Medicine
Fasting--blood
Humans
Hypoglycemic Agents--therapeutic use
Insulin--blood
Insulin Secretion
Insulin-Secreting Cells--drug effects
Models, Biological
Predictive Value of Tests
Time Factors
Treatment Outcome
HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not? [electronic resource] - Diabetes & vascular disease research Apr 2009 - 133-8 p. digital
Publication Type: Journal Article; Review
1752-8984
10.1177/1479164109336038 doi
Biomarkers--blood
Blood Glucose--metabolism
Clinical Trials as Topic
Diabetes Mellitus, Type 2--blood
Disease Progression
Evidence-Based Medicine
Fasting--blood
Humans
Hypoglycemic Agents--therapeutic use
Insulin--blood
Insulin Secretion
Insulin-Secreting Cells--drug effects
Models, Biological
Predictive Value of Tests
Time Factors
Treatment Outcome